A systematic review and meta-analysis of randomized controlled intervention trials of micronutrients on cardiovascular disease (CVD) and clinical events concluded that some but not all micronutrients may be beneficial. The analysis identified a total of 884 randomized controlled intervention trials evaluating 27 types of micronutrients among 883,627 participants (4,895,544 person-years). There was moderate- to high-quality evidence of benefit for micronutrients with important pleiotropic effects in addition to antioxidant capacity. Specifically, n-3 fatty acid supplementation decreased CVD mortality (relative risk [RR]: 0.93), myocardial infarction (RR: 0.85), and coronary heart disease events (RR: 0.86). Folic acid supplementation decreased stroke risk (RR: 0.84). Coenzyme Q10 supplementation decreased all-cause mortality (RR: 0.68). Vitamin C, D, E, and selenium showed no effect on risk of CVD or type 2 diabetes. β-carotene supplementation even increased all-cause (RR: 1.10) and CVD mortality (RR: 1.12), and stroke risk (RR: 1.09). The findings open interesting perspectives for CVD prevention and highlight the importance of micronutrient diversity and the balance of benefits and risks. Source: https://www.jacc.org/
A rigorous cohort study utilizing Taiwan’s National Health Insurance Database provides robust evidence that SGLT2…
A new study investigating the link between cerebral microbleeds (CMBs) and dementia has found that…
A comprehensive prospective study tracking over 159,000 adults for up to three decades has provided…
A comprehensive new Cochrane review of 22 studies involving nearly 2,000 participants over six months…
A large-scale study involving 103,649 UK Biobank participants has revealed that adhering to healthy dietary…
To address uncertainties in statin safety profiles, which are often based on observational data susceptible…
This website uses cookies.